This inventor holds 3 USPTO granted patents. Top assignee: Toray Industries, Inc.. Active years: 1998-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (1998 - 2002)
- Kawasaki, JP (2003)
Company Filing History:
Years Active: 1998-2003
Title: Michio Hara: Innovator in Pharmaceutical Preparations
Introduction
Michio Hara is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 3 patents, Hara's work focuses on enhancing the safety and efficacy of medicinal compositions.
Latest Patents
One of Hara's latest patents is for a sustained-release prostaglandin I derivative preparation. This preparation is designed to be highly safe and features stable drug-releasing and absorption properties. The orally administrable formulation utilizes a hydrogel base as the release-controlling component, ensuring effective delivery of the active ingredient. Another significant patent involves stable medicinal compositions containing 4,5-epoxymorphinan derivatives. This composition includes various components such as water-soluble antioxidants and surfactants, aimed at improving the stability and effectiveness of the pharmaceutical product.
Career Highlights
Hara is currently associated with Toray Industries, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug delivery systems and improving patient outcomes through better medication formulations.
Collaborations
Hara has collaborated with esteemed colleagues such as Yasuhide Horiuchi and Kaneto Uekama. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical technologies.
Conclusion
In summary, Michio Hara is a prominent inventor whose work in pharmaceutical preparations has led to significant advancements in drug delivery systems. His innovative patents reflect a commitment to improving the safety and efficacy of medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
